Enfortumab Vedotin for Treatment of Urothelial Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study
Cancer 2021 Dec 09;[EPub Ahead of Print], VS Koshkin, N Henderson, M James, D Natesan, D Freeman, A Nizam, CT Su, AR Khaki, CK Osterman, MJ Glover, R Chiang, D Makrakis, R Talukder, E Lemke, TA Olsen, J Jain, A Jang, A Ali, T Jindal, J Chou, TW Friedlander, C Hoimes, A Basu, Y Zakharia, PC Barata, MA Bilen, H Emamekhoo, NB Davis, SA Shah, MI Milowsky, S Gupta, MT Campbell, P Grivas, GP Sonpavde, D Kilari, AS AlvaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.